Morrison E, Tomasec P, Linton E A, Lowry P J, Lowenstein P R, Castro M G
Department of Physiology, School of Molecular and Medical Biosciences, University of Wales College of Cardiff, UK.
J Neuroendocrinol. 1995 Apr;7(4):263-72. doi: 10.1111/j.1365-2826.1995.tb00756.x.
Corticotrophin-releasing hormone (CRH) is a 41 amino acid neuropeptide which is cleaved at a pair of dibasic amino acids from a larger precursor molecule (pre-proCRH) by the action of endopeptidases. In cells possessing a regulated secretory pathway, sorting of proneuropeptides and prohormones occurs within the trans-Golgi network, where they are finally packaged into secretory vesicles to be released in response to an external stimulus. Such cells also possess a constitutive secretory pathway, and neuropeptides are also translocated into this subcellular compartment. We have recently established stably transfected CHO-K1 cells expressing the rat pre-proCRH cDNA, and shown that proCRH was localized within the secretory pathway and the nucleus of transfected cells. Both the cytoplasmic and nuclear species of IR-CRH displayed an apparent molecular weight approximately 19 kDa, consistent with the size of the uncleaved CRH precursor molecule. In this paper, we further characterized the bitopological, i.e. nuclear and cytoplasmic localization of proCRH within transfected CHO-K1 cells. Immunoreactive nuclear CRH was not extractable using detergents (Triton X-100 and CHAPS), 10 mM salt washes or RNase digestion but could be abolished by digestion with DNase I. These results therefore suggest that nuclear proCRH is in close association with DNA/chromatin. Treatment of transfected cells with inhibitors of protein and RNA synthesis for up to 24 h had no effect upon immunoreactive nuclear CRH, indicating that it is very stable with a long half life. Brefeldin A treatment had no effect upon the nuclear translocation of newly synthesized proCRH, suggesting that late stages of the secretory pathway (i.e. post rough endoplasmic reticulum compartments) of the transfected cells do not play a role in proCRH nuclear transport. We also demonstrate that proCRH synthesized within stably transfected CHO-K1 cells is capable of stimulating ACTH release from primary cultures of anterior pituitary cells, therefore showing for the first time that the intact precursor is also biologically active and could act as an ACTH secretagogue in-vivo.
促肾上腺皮质激素释放激素(CRH)是一种由41个氨基酸组成的神经肽,它通过内肽酶的作用从一个更大的前体分子(前促CRH)中的一对双碱性氨基酸处裂解而来。在具有调节性分泌途径的细胞中,前神经肽和前激素的分选发生在反式高尔基体网络中,在那里它们最终被包装成分泌小泡,以响应外部刺激而释放。这类细胞也具有组成型分泌途径,神经肽也会转运到这个亚细胞区室中。我们最近建立了稳定转染表达大鼠前促CRH cDNA的CHO-K1细胞,并表明促CRH定位于转染细胞的分泌途径和细胞核内。免疫反应性CRH的细胞质和细胞核形式的表观分子量约为19 kDa,与未裂解的CRH前体分子大小一致。在本文中,我们进一步对转染的CHO-K1细胞内促CRH的双拓扑结构,即细胞核和细胞质定位进行了表征。免疫反应性核CRH不能用去污剂(Triton X-100和CHAPS)、10 mM盐洗涤或核糖核酸酶消化提取,但可被脱氧核糖核酸酶I消化消除。因此,这些结果表明核促CRH与DNA/染色质紧密相关。用蛋白质和RNA合成抑制剂处理转染细胞长达24小时对免疫反应性核CRH没有影响,表明它非常稳定,半衰期很长。布雷菲德菌素A处理对新合成的促CRH的核转位没有影响,表明转染细胞分泌途径的后期阶段(即粗面内质网后区室)在促CRH核转运中不起作用。我们还证明,在稳定转染的CHO-K1细胞内合成的促CRH能够刺激原代培养的垂体前叶细胞释放促肾上腺皮质激素,因此首次表明完整的前体也具有生物活性,并且在体内可作为促肾上腺皮质激素促分泌素。